People News

Share this article:

Adamas Pharmaceuticals, a privately owned manufacturer based in California, announced two executive appointments: Michael Coffee, SVP, sales and marketing, and Amy Patrick, VP, research. Coffee was previously chief business officer for Avigen, president and chief operating officer at Amarin Pharmaceuticals, and president and COO at Elan Pharmaceuticals, among other postions. Patrick began her career at Bristol-Myers Squibb, before joining Agouron Pharmaceuticals. Most recently, she was VP, biological sciences at Genelabs Technologies.

McCann Healthcare Worldwide announced a reorganization of its medical communications divisions, including the promotion of Charlie Buckwell to worldwide head of Medical Communications, a group now comprised of McCann's Complete Medical Group and Caudex Medical. Additionally, Phill Sutcliff was promoted from CFO of Complete Medical Group and Caudex Medical to CFO global medical communications and healthcare for Europe, the Middle East and Africa. Buckwell was previously chief executive of Complete Medical Group.

Newton, MA-based Pro-Pharmaceuticals, a developer of carbohydrate-based targeted therapeutic compounds for cancer and fibrosis, announced the appointment of Arthur “Bobby” Greenberg to its board of directors. Pro-Pharmaceuticals' lead product candidate is Davanat, a treatment for colorectal cancer, currently in phase 2 of development.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Reimagining healthcare? We want to hear about it.
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters


More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media